Paolo Bossi Selected Research

Precision Medicine

12/2022	Personalized Medicine in Skull Base and Sinonasal Tumors.
11/2022	Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.
10/2020	Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm.
1/2020	Future Perspectives in the Management of Tumors of the Anterior Skull Base.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Bossi Research Topics

Disease

97	Neoplasms (Cancer) 05/2024 - 05/2004
52	Head and Neck Neoplasms (Head and Neck Cancer) 05/2024 - 11/2007
45	Squamous Cell Carcinoma of Head and Neck 05/2024 - 11/2006
26	Stomatitis 01/2024 - 11/2013
17	Mucositis 01/2024 - 02/2012
14	Pain (Aches) 01/2024 - 07/2014
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 03/2009
10	Nasopharyngeal Carcinoma 11/2023 - 01/2004
8	Carcinoma (Carcinomatosis) 03/2023 - 11/2014
8	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2022 - 01/2004
7	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2017
7	Salivary Gland Neoplasms (Salivary Gland Cancer) 11/2023 - 05/2004
7	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 07/2008
5	Cancer Pain 01/2022 - 05/2014
5	Deglutition Disorders (Dysphagia) 01/2022 - 11/2015
5	Oropharyngeal Neoplasms 01/2021 - 01/2016
4	COVID-19 12/2022 - 01/2020
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2022 - 10/2005
4	Xerostomia 01/2022 - 06/2016
4	Disease Progression 01/2022 - 01/2018
4	Nausea 02/2020 - 11/2015
3	Osteoradionecrosis 05/2024 - 01/2016
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2023 - 02/2015
3	Adenocarcinoma 12/2020 - 06/2014
3	Fatigue 10/2020 - 10/2013
3	Dermatitis 08/2020 - 10/2015
3	Vomiting 02/2020 - 11/2015
2	Osteonecrosis (Kienbock's Disease) 03/2024 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 06/2014
2	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2020
2	Sarcopenia 10/2023 - 09/2023
2	Melanoma (Melanoma, Malignant) 08/2023 - 04/2018
2	Inflammation (Inflammations) 01/2023 - 10/2022
2	Carcinogenesis 11/2022 - 02/2015
2	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2009
2	Trismus (Lockjaw) 01/2022 - 06/2016
2	Neutropenia 01/2021 - 11/2016
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2020
2	Diarrhea 10/2019 - 10/2013
2	Paranasal Sinus Neoplasms 02/2016 - 12/2015

Drug/Important Bio-Agent (IBA)

14	PlatinumIBA 01/2024 - 10/2005
13	Cetuximab (Erbitux)FDA Link 10/2023 - 10/2005
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2006
12	Cisplatin (Platino)FDA LinkGeneric 03/2023 - 01/2004
10	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 11/2006
7	Opioid Analgesics (Opioids)IBA 01/2022 - 05/2014
6	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2020
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 01/2004
5	Benzydamine (Tantum)IBA 01/2024 - 10/2019
5	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 05/2004
4	Anesthetics (Anesthetic Agents)IBA 01/2024 - 11/2013
4	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
4	Analgesics (Analgesic Drugs)IBA 05/2020 - 11/2013
3	pembrolizumabIBA 04/2024 - 01/2023
3	NivolumabIBA 01/2024 - 05/2021
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023 - 05/2020
3	CytokinesIBA 11/2023 - 12/2016
3	phytobacteriomycin (PBM)IBA 07/2023 - 10/2019
3	cemiplimabIBA 01/2023 - 11/2021
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2017
3	AndrogensIBA 12/2021 - 06/2014
3	Fentanyl (Sublimaze)FDA LinkGeneric 05/2020 - 09/2014
2	Denosumab FDA Link 03/2024 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 12/2016
2	Morphine (MS Contin)FDA LinkGeneric 12/2022 - 05/2020
2	Vitamin D FDA LinkGeneric 01/2022 - 09/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2021
2	TabletsIBA 07/2021 - 01/2020
2	Chewing Gum (Chewing Gums)IBA 07/2021 - 05/2020
2	VitaminsIBA 07/2021 - 10/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 02/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 02/2020
2	Leucovorin (Folinic Acid)FDA Link 12/2020 - 01/2020
2	AntiemeticsIBA 02/2020 - 11/2015
2	lenvatinibIBA 01/2020 - 04/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 04/2018
2	HhAntag691IBA 01/2018 - 02/2015
2	Monoclonal AntibodiesIBA 01/2018 - 11/2017

Therapy/Procedure

62	Therapeutics 03/2024 - 06/2014
55	Radiotherapy 05/2024 - 01/2004
49	Drug Therapy (Chemotherapy) 11/2023 - 01/2004
26	Immunotherapy 05/2024 - 04/2018
17	Chemoradiotherapy 09/2023 - 11/2009
9	Induction Chemotherapy 10/2023 - 11/2015
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2020 - 05/2004
6	Nutritional Support (Artificial Feeding) 03/2024 - 07/2014
4	Precision Medicine 12/2022 - 01/2020
3	Adjuvant Radiotherapy 12/2023 - 01/2022
3	Re-Irradiation 09/2023 - 05/2021
3	Low-Level Light Therapy (LLLT) 07/2023 - 10/2019
3	Neoadjuvant Therapy 11/2022 - 02/2010
3	Pain Management 01/2022 - 08/2018
3	Combined Modality Therapy 01/2019 - 12/2015
2	Castration 03/2024 - 12/2021
2	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 02/2020
2	Hematopoietic Stem Cell Transplantation 01/2022 - 10/2019
2	Aftercare (After-Treatment) 01/2018 - 12/2016
2	Chemoprevention 02/2015 - 07/2008